125 related articles for article (PubMed ID: 11021430)
1. Activated partial thromboplastin time as a screening test of minor or moderate coagulation factor deficiencies for canine plasma: sensitivity of different commercial reagents.
Mischke R
J Vet Diagn Invest; 2000 Sep; 12(5):433-7. PubMed ID: 11021430
[TBL] [Abstract][Full Text] [Related]
2. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
Mischke R
Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
[TBL] [Abstract][Full Text] [Related]
3. Influence of factor VIII:C and factor IX activity in plasmas of haemophilic dogs on the activated partial thromboplastin time measured with two commercial reagents.
Mischke R
Haemophilia; 2000 May; 6(3):135-9. PubMed ID: 10792470
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
Mischke R
Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
[TBL] [Abstract][Full Text] [Related]
5. Commercial variants of the prothrombin time test as a screening test of acquired coagulation factor II, VII, and X deficiencies in dogs.
Mischke R
Res Vet Sci; 2002 Oct; 73(2):165-70. PubMed ID: 12204636
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of commercial prothrombin time reagents to detect coagulation factor deficiencies in equine plasma.
Mischke R; Junker J; Deegen E
Vet J; 2006 Jan; 171(1):114-9. PubMed ID: 16427588
[TBL] [Abstract][Full Text] [Related]
7. In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies.
Toulon P; Eloit Y; Smahi M; Sigaud C; Jambou D; Fischer F; Appert-Flory A
Int J Lab Hematol; 2016 Aug; 38(4):389-96. PubMed ID: 27185477
[TBL] [Abstract][Full Text] [Related]
8. [The effect of factor VIII:C activity on the activated partial thromboplastin time (aPTT) in the dog. Adaptation of the aPTT as a screening test for canine hemophilia A?].
Mischke R
Dtsch Tierarztl Wochenschr; 1993 Jun; 100(6):219-22. PubMed ID: 8339706
[TBL] [Abstract][Full Text] [Related]
9. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
Favaloro EJ; Kershaw G; Mohammed S; Lippi G
Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
[TBL] [Abstract][Full Text] [Related]
10. Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?
Martinuzzo M; Barrera L; Rodriguez M; D'Adamo MA; López MS; Otaso JC
Int J Lab Hematol; 2015 Dec; 37(6):853-60. PubMed ID: 26338156
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.
Johnstone IB; Martin CA
Can J Vet Res; 2000 Apr; 64(2):117-22. PubMed ID: 10805251
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of three activated partial thromboplastin time reagents to coagulation factor deficiencies.
Turi DC; Peerschke EI
Am J Clin Pathol; 1986 Jan; 85(1):43-9. PubMed ID: 3940420
[TBL] [Abstract][Full Text] [Related]
13. Heparin in vitro sensitivity of the activated partial thromboplastin time in canine plasma depends on reagent.
Mischke R
J Vet Diagn Invest; 2003 Nov; 15(6):588-91. PubMed ID: 14667026
[TBL] [Abstract][Full Text] [Related]
14. [Test for detection of activated partial thromboplastin time using ellagic acid].
Berkovskiĭ AL; Sergeeva EV; Kachalova ND; Prostakova TM; Kozlov AA
Klin Lab Diagn; 1999 Jun; (6):18-20. PubMed ID: 10459199
[TBL] [Abstract][Full Text] [Related]
15. Performance of Activated Partial Thromboplastin Time (APTT): Determining Reagent Sensitivity to Factor Deficiencies, Heparin, and Lupus Anticoagulants.
Kershaw G
Methods Mol Biol; 2017; 1646():75-83. PubMed ID: 28804819
[TBL] [Abstract][Full Text] [Related]
16. Activated partial thromboplastin time. A multicenter evaluation of 11 reagents in the screening of mild haemophilia A.
Scand J Haematol; 1980 Oct; 25(4):308-17. PubMed ID: 6782653
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the sensitivity of commercial APTT reagents in the detection of mild coagulopathies.
Marlar RA; Bauer PJ; Endres-Brooks JL; Montgomery RR; Miller CM; Schanen MM
Am J Clin Pathol; 1984 Oct; 82(4):436-9. PubMed ID: 6475840
[TBL] [Abstract][Full Text] [Related]
18. Comparison of four commercially available activated partial thromboplastin time reagents using a semi-automated coagulometer.
Shetty S; Ghosh K; Mohanty D
Blood Coagul Fibrinolysis; 2003 Jul; 14(5):493-7. PubMed ID: 12851537
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization.
Fritsma GA; Dembitzer FR; Randhawa A; Marques MB; Van Cott EM; Adcock-Funk D; Peerschke EI
Am J Clin Pathol; 2012 Jun; 137(6):904-8. PubMed ID: 22586049
[TBL] [Abstract][Full Text] [Related]
20. Effect of citrate concentration on coagulation test results in dogs.
Stokol T; Brooks MB; Erb HN
J Am Vet Med Assoc; 2000 Dec; 217(11):1672-7. PubMed ID: 11110458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
